Erasing Unpleasant Memories with a Genetic Switch
News Jul 01, 2016
Dementia, accidents, or traumatic events can make us lose the memories formed before the injury or the onset of the disease. Researchers from KU Leuven and the Leibniz Institute for Neurobiology have now shown that some memories can also be erased when one particular gene is switched off.
The team trained mice that had been genetically modified in one single gene: neuroplastin. This gene, which is investigated by only a few groups in the world, is very important for brain plasticity. In humans, changes in the regulation of the neuroplastin gene have recently been linked to decreased intellectual abilities and schizophrenia.
In the reported study, the mice were trained to move from one side of a box to the other as soon as a lamp lights up, thus avoiding a foot stimulus. This learning process is called associative learning. Its most famous example is Pavlov’s dog: conditioned to associate the sound of a bell with getting food, the dog starts salivating whenever it hears a bell.
When the scientists switched off the neuroplastin gene after conditioning, the mice were no longer able to perform the task properly. In other words, they showed learning and memory deficits that were specifically related to associative learning. The control mice with the neuroplastin gene switched on, by contrast, could still do the task perfectly.
Professor Detlef Balschun from the KU Leuven Laboratory for Biological Psychology: “We were amazed to find that deactivating one single gene is enough to erase associative memories formed before or during the learning trials. Switching off the neuroplastin gene has an impact on the behaviour of the mice, because it interferes with the communication between their brain cells.”
By measuring the electrical signals in the brain, the KU Leuven team discovered clear deficits in the cellular mechanism used to store memories. These changes are even visible at the level of individual brain cells, as postdoctoral researcher Victor Sabanov was able to show.
“This is still basic research,” Balschun adds. “We still need further research to show whether neuroplastin also plays a role in other forms of learning.”
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE